Skip to main content
Premium Trial:

Request an Annual Quote

Expression Analysis and InPharmix Announce Collaboration

NEW YORK, Dec. 17 (GenomeWeb News) -- Durham, NC-based microarray-services firm Expression Analysis today announced an alliance with Greenwood, Indiana-based InPharmix, a bioinformatics and literature-mining services provider.

 

Financial details of the deal were not disclosed.

 

Under the collaboration, Expression Analysis will offer users of its Affymetrix-based microarray analysis services comparisons to relevant information derived from InPharmix's PDQ_MED literature search product.

The Scan

Fertility Fraud Found

Consumer genetic testing has uncovered cases of fertility fraud that are leading to lawsuits, according to USA Today.

Ties Between Vigorous Exercise, ALS in Genetically At-Risk People

Regular strenuous exercise could contribute to motor neuron disease development among those already at genetic risk, Sky News reports.

Test Warning

The Guardian writes that the US regulators have warned against using a rapid COVID-19 test that is a key part of mass testing in the UK.

Science Papers Examine Feedback Mechanism Affecting Xist, Continuous Health Monitoring for Precision Medicine

In Science this week: analysis of cis confinement of the X-inactive specific transcript, and more.